Cargando…
The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections
PURPOSE: Symptoms such as nausea, vomiting, tightness of the chest, bradycardia, and shoulder or abdominal discomfort, caused by vagotonia occurring during uterus manipulation, have concerned healthcare professionals for some time. Patients sometimes report these symptoms when undergoing spinal anes...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627848/ https://www.ncbi.nlm.nih.gov/pubmed/28746222 http://dx.doi.org/10.1097/MD.0000000000007624 |
_version_ | 1783268780845039616 |
---|---|
author | Chen, Shih-Hong Chen, Shiou-Sheng Chang, Ching-Tao Huang, Chi-Hsiang Fan, Shou-Zen Chen, Li-Kuei |
author_facet | Chen, Shih-Hong Chen, Shiou-Sheng Chang, Ching-Tao Huang, Chi-Hsiang Fan, Shou-Zen Chen, Li-Kuei |
author_sort | Chen, Shih-Hong |
collection | PubMed |
description | PURPOSE: Symptoms such as nausea, vomiting, tightness of the chest, bradycardia, and shoulder or abdominal discomfort, caused by vagotonia occurring during uterus manipulation, have concerned healthcare professionals for some time. Patients sometimes report these symptoms when undergoing spinal anesthesia for cesarean sections (CSs). We designed a prospective, double-blind study to investigate the effectiveness of tenoxicam in preventing these symptoms of discomfort. METHODS: A total of 105 American Society of Anesthesiologists (ASA) class I-II nulliparous pregnant women, who were scheduled for a CS, were enrolled into this prospective, double-blind study. Spinal anesthesia was conducted to reach a peak dermatome level of no more than T3. The 100 patients were randomly divided into 2 groups having completed study course: Group T (N = 50) received a 20 mg dose of tenoxicam in 5 mL of normal saline (NS) immediately after skin incision and Group N (N = 50) only received 5 mL NS. The incidence and severity of the symptoms experienced by the patients were recorded by a nurse anesthetist who was blinded to the injection regimen the patients were receiving. A chi-square test was used for statistical analysis t test and P < .05 was defined as significant. RESULTS: The incidence and degree of severity of nausea and vomiting were same in both the groups. The incidence and degree of severity of bradycardia, nausea, vomiting, tightness of the chest, shoulder discomfort, and abdominal discomfort were lower in Group T than in Group N. CONCLUSION: Tenoxicam might theoretically block the parasympathetic vagus pathway and decrease the visceral pain or visceral-specific symptoms, alleviating the symptoms caused by vagotonia. However, the prophylactic effect of tenoxicam in reducing the incidence and severity of nausea and vomiting was not statistically significant. This could be because nausea and vomiting are not solely caused by vagotonia, but also by other mechanisms. |
format | Online Article Text |
id | pubmed-5627848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-56278482017-10-12 The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections Chen, Shih-Hong Chen, Shiou-Sheng Chang, Ching-Tao Huang, Chi-Hsiang Fan, Shou-Zen Chen, Li-Kuei Medicine (Baltimore) 3300 PURPOSE: Symptoms such as nausea, vomiting, tightness of the chest, bradycardia, and shoulder or abdominal discomfort, caused by vagotonia occurring during uterus manipulation, have concerned healthcare professionals for some time. Patients sometimes report these symptoms when undergoing spinal anesthesia for cesarean sections (CSs). We designed a prospective, double-blind study to investigate the effectiveness of tenoxicam in preventing these symptoms of discomfort. METHODS: A total of 105 American Society of Anesthesiologists (ASA) class I-II nulliparous pregnant women, who were scheduled for a CS, were enrolled into this prospective, double-blind study. Spinal anesthesia was conducted to reach a peak dermatome level of no more than T3. The 100 patients were randomly divided into 2 groups having completed study course: Group T (N = 50) received a 20 mg dose of tenoxicam in 5 mL of normal saline (NS) immediately after skin incision and Group N (N = 50) only received 5 mL NS. The incidence and severity of the symptoms experienced by the patients were recorded by a nurse anesthetist who was blinded to the injection regimen the patients were receiving. A chi-square test was used for statistical analysis t test and P < .05 was defined as significant. RESULTS: The incidence and degree of severity of nausea and vomiting were same in both the groups. The incidence and degree of severity of bradycardia, nausea, vomiting, tightness of the chest, shoulder discomfort, and abdominal discomfort were lower in Group T than in Group N. CONCLUSION: Tenoxicam might theoretically block the parasympathetic vagus pathway and decrease the visceral pain or visceral-specific symptoms, alleviating the symptoms caused by vagotonia. However, the prophylactic effect of tenoxicam in reducing the incidence and severity of nausea and vomiting was not statistically significant. This could be because nausea and vomiting are not solely caused by vagotonia, but also by other mechanisms. Wolters Kluwer Health 2017-07-28 /pmc/articles/PMC5627848/ /pubmed/28746222 http://dx.doi.org/10.1097/MD.0000000000007624 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 3300 Chen, Shih-Hong Chen, Shiou-Sheng Chang, Ching-Tao Huang, Chi-Hsiang Fan, Shou-Zen Chen, Li-Kuei The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections |
title | The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections |
title_full | The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections |
title_fullStr | The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections |
title_full_unstemmed | The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections |
title_short | The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections |
title_sort | use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections |
topic | 3300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627848/ https://www.ncbi.nlm.nih.gov/pubmed/28746222 http://dx.doi.org/10.1097/MD.0000000000007624 |
work_keys_str_mv | AT chenshihhong theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT chenshiousheng theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT changchingtao theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT huangchihsiang theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT fanshouzen theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT chenlikuei theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT chenshihhong useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT chenshiousheng useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT changchingtao useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT huangchihsiang useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT fanshouzen useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections AT chenlikuei useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections |